Holen Sie sich die Stockscreener-App
1.05
6.67%
-0.075
Handel nachbörslich:
1.05
Schlusskurs vom Vortag:
$1.125
Offen:
$1.11
24-Stunden-Volumen:
163.07K
Relative Volume:
0.17
Marktkapitalisierung:
$5.28M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-28.70M
KGV:
-0.0212
EPS:
-49.5275
Netto-Cashflow:
$-3.22M
1W Leistung:
-9.48%
1M Leistung:
-26.57%
6M Leistung:
-93.82%
1J Leistung:
-95.47%
1-Tages-Spanne:
$1.04
$1.16
1-Wochen-Bereich:
$1.04
$1.325
52-Wochen-Spanne:
$1.04
$35.01
Aspire Biopharma Holdings Inc Stock (ASBP) Company Profile
Firmenname
Aspire Biopharma Holdings Inc
Sektor
Branche
Telefon
561-704-8527
Adresse
23150 FASHION DRIVE, SUITE 232, ESTERO
Compare ASBP vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ASBP
Aspire Biopharma Holdings Inc
|
1.05 | 5.65M | 0 | -28.70M | -3.22M | -49.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.34 | 121.46B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
745.77 | 78.93B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
700.45 | 43.87B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
313.41 | 42.07B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.05 | 31.65B | 5.36B | 287.73M | 924.18M | 2.5229 |
Aspire Biopharma Holdings Inc Aktie (ASBP) Neueste Nachrichten
Aspire Biopharma's Subsidiary to Feature BUZZ BOMB(TM) at The Health & Fitness Show 2026 - Black Hills Pioneer
Aspire Biopharma Scales Consumer Division with Delivery of Two Million BUZZ BOMB(TM) Units Featuring Modernized Brand Identity - Times Herald-Record
Sprinkle-under-tongue caffeine sticks arrive at major 2026 fitness show - Stock Titan
Aspire Biopharma Engages with Global Pharmaceutical Leaders at CPHI Frankfurt to Advance Partnership Discussions for its Sublingual High-Dose Aspirin - Springfield News-Leader
Aspire Biopharma's BUZZ BOMB(TM) Disrupts Energy Category with New Convenience Store Pack - Corpus Christi Caller-Times
Aspire Biopharma's Wholly Owned Subsidiary, Buzz Bomb Caffeine Company, Partners with Blue Shark Beverages to Expand Southern California Distribution - Enterprise News
Aspire Biopharma's Wholly Owned Subsidiary, Buzz Bomb Caffeine Company, to Showcase BUZZ BOMB(TM) Caffeine and its Innovative Sublingual Delivery Technology at The Sports & Active Nutrition Summit - Peoria Journal Star
Aspire Biopharma Partners with Microsize to Develop Rapid-delivery Sublingual Powder Formulation of Alprazolam for Faster Anxiety Relief - ACCESS Newswire
Aspire Biopharma's Unveils Bold New Era for BUZZ BOMB(TM) Caffeine with Dynamic Website and Packaging Redesign - Peoria Journal Star
ASBP SEC FilingsAspire Biopharma Holdings Inc 10-K, 10-Q, 8-K Forms - Stock Titan
ASBP Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Aspire Biopharma Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements - The Sheboygan Press
Aspire Biopharma Provides Q3 2025 Business Update - Las Cruces Sun-News
Aspire Biopharma Announces Reverse Stock Split - Daily American
Aspire Biopharma Holdings, Inc.Common Stock (NQ: ASBP - The Chronicle-Journal
ASBP Technical Analysis & Stock Price Forecast - Intellectia AI
ASBP Technical Analysis & ETF Price Forecast - Intellectia AI
ASBP Should I Buy - Intellectia AI
Aspire Biopharma's Buzz Bomb(TM) Caffeine Company Achieves Record Social Media Growth and Sales Surge Following World-Record Marathon Sponsorship - Digital Journal
Aspire Biopharma Holdings, Inc.: Aspire Biopharma's Buzz Bomb Caffeine Company Achieves Record Social Media Growth and Sales Surge Following World-Record Marathon Sponsorship - FinanzNachrichten.de
Ashley Paulson’s 100-mile world record drives 400K Buzz Bomb views - Stock Titan
Finanzdaten der Aspire Biopharma Holdings Inc-Aktie (ASBP)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):